Want to see SE:SUS full AI Analyst Report?
Total Valuation
Surgical Science Sweden AB has a market cap or net worth of kr2.00B. The enterprise value is kr964.04.
Market Capkr2.00B
Enterprise Valuekr964.04
Share Statistics
Surgical Science Sweden AB has 51,026,237 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,026,237
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Surgical Science Sweden AB’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.64%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.64%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee3.13M
Profits Per Employee210.78K
Employee Count317
Asset Turnover0.21
Inventory Turnover2.02
Valuation Ratios
The current PE Ratio of Surgical Science Sweden AB is 47.3. Surgical Science Sweden AB’s PEG ratio is -0.50.
PE Ratio47.3
PS Ratio1.67
PB Ratio0.39
Price to Fair Value0.39
Price to FCF24.35
Price to Operating Cash Flow16.58
PEG Ratio-0.50
Income Statement
In the last 12 months, Surgical Science Sweden AB had revenue of 992.34M and earned 66.82M in profits. Earnings per share was 1.31.
Revenue992.34M
Gross Profit576.90M
Operating Income108.97M
Pretax Income100.14M
Net Income66.82M
EBITDA192.34M
Earnings Per Share (EPS)1.31
Cash Flow
In the last 12 months, operating cash flow was 149.13M and capital expenditures -43.08M, giving a free cash flow of 106.05M billion.
Operating Cash Flow149.13M
Free Cash Flow106.05M
Free Cash Flow per Share2.08
Dividends & Yields
Surgical Science Sweden AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-51.24%
50-Day Moving Average33.22
200-Day Moving Average36.73
Relative Strength Index (RSI)84.39
Average Volume (3m)1.61M
Important Dates
Surgical Science Sweden AB upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 19, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Surgical Science Sweden AB as a current ratio of 4.07, with Debt / Equity ratio of 0.05%
Current Ratio4.07
Quick Ratio3.36
Debt to Market Cap0.01
Net Debt to EBITDA-2.79
Interest Coverage Ratio17.34
Taxes
In the past 12 months, Surgical Science Sweden AB has paid 33.32M in taxes.
Income Tax33.32M
Effective Tax Rate0.33
Enterprise Valuation
Surgical Science Sweden AB EV to EBITDA ratio is 5.83, with an EV/FCF ratio of 16.45.
EV to Sales1.13
EV to EBITDA5.83
EV to Free Cash Flow16.45
EV to Operating Cash Flow14.05
Balance Sheet
Surgical Science Sweden AB has kr658.39M in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr658.39M billion.
Cash & Marketable Securitieskr658.39M
Total Debtkr0.00
Net Cashkr658.39M
Net Cash Per Sharekr12.90
Tangible Book Value Per Sharekr17.11
Margins
Gross margin is 63.12%, with operating margin of 10.98%, and net profit margin of 6.73%.
Gross Margin63.12%
Operating Margin10.98%
Pretax Margin10.09%
Net Profit Margin6.73%
EBITDA Margin19.38%
EBIT Margin10.98%
Analyst Forecast
The average price target for Surgical Science Sweden AB is kr45.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Targetkr45.00
Price Target Upside45.91% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast8.40%
EPS Growth Forecast0.74%